Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR GLUCOSE - ANVISA Registration 80975210014

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80975210014 and manufactured by TOCARE INDUSTRIA E COMERCIO DE PRODUTOS MEDICOS S/A. The registration is held by TOCARE INDUSTRIA E COMERCIO DE PRODUTOS MEDICOS S/A with validity until Jul 10, 2033.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including OK BIOTECH CO., LTD., ROCHE DIABETES CARE GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80975210014
Registration Details
ANVISA Registration Number: 80975210014
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Tiras Reagentes para mediรงรฃo de Glicose no Sangue TC01
Risk Class III

Registration Details

80975210014

25351148861202313

17513528000167

Company Information

Brazil
PT: BRASIL

Dates and Status

Jul 10, 2023

10/07/2033

09/18/2025 19:00:01